Latest stories

  • in

    CDSCO Panel Grants Abbott’s Protocol Amendment Proposal For Ursodeoxycholic Acid

    CDSCO Panel Grants Abbott's Protocol Amendment Proposal For Ursodeoxycholic Acid

    New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has accepted Abbott’s phase III clinical trial protocol amendment proposal for Ursodeoxycholic Acid Tablets IP 150 mg, 300 mg, 450 mg, and 600 mg with respect to inclusion and exclusion criteria. Ursodeoxycholic acid, or ursodiol, is a naturally occurring […] More

  • in

    Syngene Proposal To Conduct Phase I CT of Ferumoxytol Inj rejected by CDSCO panel

    New Delhi: Stating that the proposal submitted by Syngene International could not be considered at present, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has rejected the proposal to conduct the Phase I clinical trial of Ferumoxytol injection. The drug to be used in the proposed trial is not […] More

  • in

    Following NMC Draft Proposal, Govt Considering Common Counselling for admission to MBBS, PG medical courses: Report

    New Delhi: Following the NMC Draft Graduate Medical Education Regulations 2023, now the Union Government is also considering the possibility for a common counselling for all MBBS and PG Medical seats in the country. Confirming this move by the National Medical Commission (NMC), an official in the Union Health Minister recently informed TOI that the proposal […] More